U.S. Markets closed

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
255.71+0.58 (+0.23%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close249.62
Open251.10
Bid252.00 x 800
Ask255.09 x 800
Day's Range250.50 - 257.00
52 Week Range207.33 - 276.69
Volume2,272,190
Avg. Volume2,765,598
Market Cap147.238B
Beta (5Y Monthly)0.74
PE Ratio (TTM)20.77
EPS (TTM)12.31
Earnings DateApr 28, 2021 - May 03, 2021
Forward Dividend & Yield7.04 (2.75%)
Ex-Dividend DateMay 14, 2021
1y Target Est255.93
  • Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
    PR Newswire

    Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

    Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prime Therapeutics (NASDAQ:FPRX), a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, for $38.00 per share in cash. The aggregate consideration to be paid by Amgen to complete the tender offer and the subsequent merger is approximately $1.9 billion without giving effect to related transaction fees and expenses.

  • Top Stock Reports for Abbott, salesforce & BHP
    Zacks

    Top Stock Reports for Abbott, salesforce & BHP

    Top Stock Reports for Abbott, salesforce & BHP

  • Amgen Looks Ready for an Upside Breakout
    TheStreet.com

    Amgen Looks Ready for an Upside Breakout

    Amgen has been in a long-term uptrend but the stock has been stalled for the past year. The indicators I favor are looking more positive so let's check out the charts to see if this is the time to buy.